FDA authorizes Abbott's wearable to monitor ketone and glucose in diabetes patients

The FDA authorized Abbott Laboratories’ new glucose monitor, the first device to continuously track both ketone levels and blood sugar. This is a regulatory milestone that supports product differentiation in diabetes management, which should be viewed as modestly positive for Abbott’s prospects.